4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-124510
Chief Executive Officer acquired 196,316 shares (conversion)
- Chief Executive Officer returned 196,316 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Santos da Silva Jorge · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-19 | Conversion : show line 1 in the form | +196,316 | 3,074,893 | D |
| 2025-12-19 | Returned to the company : show line 2 in the form | −196,316 | 0 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-19 | Conversion : show line 3 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG | −5,836 | 0 | D |
Loading xslF345X05/ownership.xml…